Given the relevance of the CD55–CD97 complex in immune disorders and carcinomas, elucidating this unique complex structure may provide insights for pharmaceutical development and a greater understanding of the mechanisms of the human body’s signaling pathways. This evidence concerns the gene ADGRE2 and immune system disorder.